Report cover image

Global Pain Management Drugs Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Jul 16, 2025
Length 199 Pages
SKU # APRC20283974

Description

Summary

According to APO Research, The global Pain Management Drugs market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Pain Management Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Pain Management Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Pain Management Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Pain Management Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Pain Management Drugs include GSK, Allergan, Assertio Therapeutics, Eli Lilly, Endo, Grunenthal, J&J, Teikoku Seiyaku and Yunnan Baiyao, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Pain Management Drugs, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Pain Management Drugs, also provides the revenue of main regions and countries. Of the upcoming market potential for Pain Management Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pain Management Drugs revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Pain Management Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Pain Management Drugs revenue, projected growth trends, production technology, application and end-user industry.

Pain Management Drugs Segment by Company

GSK
Allergan
Assertio Therapeutics
Eli Lilly
Endo
Grunenthal
J&J
Teikoku Seiyaku
Yunnan Baiyao
AstraZeneca
Bayer
Pfizer
Merck
Sanofi
Teva
Pain Management Drugs Segment by Type

Branded Opioids
Generic Opioids
NSAIDs
Others
Pain Management Drugs Segment by Application

Hospitals
Drugstores
Others
Pain Management Drugs Segment by Region

North America
United States
Canada
Europe

Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific

China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America

Mexico
Brazil
Argentina
Colombia
Middle East & Africa

Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pain Management Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pain Management Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pain Management Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Pain Management Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Pain Management Drugs company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pain Management Drugs revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

199 Pages
1 Market Overview
1.1 Product Definition
1.2 Pain Management Drugs Market by Type
1.2.1 Global Pain Management Drugs Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Branded Opioids
1.2.3 Generic Opioids
1.2.4 NSAIDs
1.2.5 Others
1.3 Pain Management Drugs Market by Application
1.3.1 Global Pain Management Drugs Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Pain Management Drugs Market Dynamics
2.1 Pain Management Drugs Industry Trends
2.2 Pain Management Drugs Industry Drivers
2.3 Pain Management Drugs Industry Opportunities and Challenges
2.4 Pain Management Drugs Industry Restraints
3 Global Growth Perspective
3.1 Global Pain Management Drugs Market Perspective (2020-2031)
3.2 Global Pain Management Drugs Growth Trends by Region
3.2.1 Global Pain Management Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Pain Management Drugs Market Size by Region (2020-2025)
3.2.3 Global Pain Management Drugs Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Pain Management Drugs Revenue by Players
4.1.1 Global Pain Management Drugs Revenue by Players (2020-2025)
4.1.2 Global Pain Management Drugs Revenue Market Share by Players (2020-2025)
4.1.3 Global Pain Management Drugs Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Pain Management Drugs Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Pain Management Drugs Key Players Headquarters & Area Served
4.4 Global Pain Management Drugs Players, Product Type & Application
4.5 Global Pain Management Drugs Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Pain Management Drugs Market CR5 and HHI
4.6.3 2024 Pain Management Drugs Tier 1, Tier 2, and Tier 3
5 Pain Management Drugs Market Size by Type
5.1 Global Pain Management Drugs Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Pain Management Drugs Revenue by Type (2020-2031)
5.3 Global Pain Management Drugs Revenue Market Share by Type (2020-2031)
6 Pain Management Drugs Market Size by Application
6.1 Global Pain Management Drugs Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Pain Management Drugs Revenue by Application (2020-2031)
6.3 Global Pain Management Drugs Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 GSK
7.1.1 GSK Comapny Information
7.1.2 GSK Business Overview
7.1.3 GSK Pain Management Drugs Revenue and Gross Margin (2020-2025)
7.1.4 GSK Pain Management Drugs Product Portfolio
7.1.5 GSK Recent Developments
7.2 Allergan
7.2.1 Allergan Comapny Information
7.2.2 Allergan Business Overview
7.2.3 Allergan Pain Management Drugs Revenue and Gross Margin (2020-2025)
7.2.4 Allergan Pain Management Drugs Product Portfolio
7.2.5 Allergan Recent Developments
7.3 Assertio Therapeutics
7.3.1 Assertio Therapeutics Comapny Information
7.3.2 Assertio Therapeutics Business Overview
7.3.3 Assertio Therapeutics Pain Management Drugs Revenue and Gross Margin (2020-2025)
7.3.4 Assertio Therapeutics Pain Management Drugs Product Portfolio
7.3.5 Assertio Therapeutics Recent Developments
7.4 Eli Lilly
7.4.1 Eli Lilly Comapny Information
7.4.2 Eli Lilly Business Overview
7.4.3 Eli Lilly Pain Management Drugs Revenue and Gross Margin (2020-2025)
7.4.4 Eli Lilly Pain Management Drugs Product Portfolio
7.4.5 Eli Lilly Recent Developments
7.5 Endo
7.5.1 Endo Comapny Information
7.5.2 Endo Business Overview
7.5.3 Endo Pain Management Drugs Revenue and Gross Margin (2020-2025)
7.5.4 Endo Pain Management Drugs Product Portfolio
7.5.5 Endo Recent Developments
7.6 Grunenthal
7.6.1 Grunenthal Comapny Information
7.6.2 Grunenthal Business Overview
7.6.3 Grunenthal Pain Management Drugs Revenue and Gross Margin (2020-2025)
7.6.4 Grunenthal Pain Management Drugs Product Portfolio
7.6.5 Grunenthal Recent Developments
7.7 J&J
7.7.1 J&J Comapny Information
7.7.2 J&J Business Overview
7.7.3 J&J Pain Management Drugs Revenue and Gross Margin (2020-2025)
7.7.4 J&J Pain Management Drugs Product Portfolio
7.7.5 J&J Recent Developments
7.8 Teikoku Seiyaku
7.8.1 Teikoku Seiyaku Comapny Information
7.8.2 Teikoku Seiyaku Business Overview
7.8.3 Teikoku Seiyaku Pain Management Drugs Revenue and Gross Margin (2020-2025)
7.8.4 Teikoku Seiyaku Pain Management Drugs Product Portfolio
7.8.5 Teikoku Seiyaku Recent Developments
7.9 Yunnan Baiyao
7.9.1 Yunnan Baiyao Comapny Information
7.9.2 Yunnan Baiyao Business Overview
7.9.3 Yunnan Baiyao Pain Management Drugs Revenue and Gross Margin (2020-2025)
7.9.4 Yunnan Baiyao Pain Management Drugs Product Portfolio
7.9.5 Yunnan Baiyao Recent Developments
7.10 AstraZeneca
7.10.1 AstraZeneca Comapny Information
7.10.2 AstraZeneca Business Overview
7.10.3 AstraZeneca Pain Management Drugs Revenue and Gross Margin (2020-2025)
7.10.4 AstraZeneca Pain Management Drugs Product Portfolio
7.10.5 AstraZeneca Recent Developments
7.11 Bayer
7.11.1 Bayer Comapny Information
7.11.2 Bayer Business Overview
7.11.3 Bayer Pain Management Drugs Revenue and Gross Margin (2020-2025)
7.11.4 Bayer Pain Management Drugs Product Portfolio
7.11.5 Bayer Recent Developments
7.12 Pfizer
7.12.1 Pfizer Comapny Information
7.12.2 Pfizer Business Overview
7.12.3 Pfizer Pain Management Drugs Revenue and Gross Margin (2020-2025)
7.12.4 Pfizer Pain Management Drugs Product Portfolio
7.12.5 Pfizer Recent Developments
7.13 Merck
7.13.1 Merck Comapny Information
7.13.2 Merck Business Overview
7.13.3 Merck Pain Management Drugs Revenue and Gross Margin (2020-2025)
7.13.4 Merck Pain Management Drugs Product Portfolio
7.13.5 Merck Recent Developments
7.14 Sanofi
7.14.1 Sanofi Comapny Information
7.14.2 Sanofi Business Overview
7.14.3 Sanofi Pain Management Drugs Revenue and Gross Margin (2020-2025)
7.14.4 Sanofi Pain Management Drugs Product Portfolio
7.14.5 Sanofi Recent Developments
7.15 Teva
7.15.1 Teva Comapny Information
7.15.2 Teva Business Overview
7.15.3 Teva Pain Management Drugs Revenue and Gross Margin (2020-2025)
7.15.4 Teva Pain Management Drugs Product Portfolio
7.15.5 Teva Recent Developments
8 North America
8.1 North America Pain Management Drugs Revenue (2020-2031)
8.2 North America Pain Management Drugs Revenue by Type (2020-2031)
8.2.1 North America Pain Management Drugs Revenue by Type (2020-2025)
8.2.2 North America Pain Management Drugs Revenue by Type (2026-2031)
8.3 North America Pain Management Drugs Revenue Share by Type (2020-2031)
8.4 North America Pain Management Drugs Revenue by Application (2020-2031)
8.4.1 North America Pain Management Drugs Revenue by Application (2020-2025)
8.4.2 North America Pain Management Drugs Revenue by Application (2026-2031)
8.5 North America Pain Management Drugs Revenue Share by Application (2020-2031)
8.6 North America Pain Management Drugs Revenue by Country
8.6.1 North America Pain Management Drugs Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Pain Management Drugs Revenue by Country (2020-2025)
8.6.3 North America Pain Management Drugs Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Pain Management Drugs Revenue (2020-2031)
9.2 Europe Pain Management Drugs Revenue by Type (2020-2031)
9.2.1 Europe Pain Management Drugs Revenue by Type (2020-2025)
9.2.2 Europe Pain Management Drugs Revenue by Type (2026-2031)
9.3 Europe Pain Management Drugs Revenue Share by Type (2020-2031)
9.4 Europe Pain Management Drugs Revenue by Application (2020-2031)
9.4.1 Europe Pain Management Drugs Revenue by Application (2020-2025)
9.4.2 Europe Pain Management Drugs Revenue by Application (2026-2031)
9.5 Europe Pain Management Drugs Revenue Share by Application (2020-2031)
9.6 Europe Pain Management Drugs Revenue by Country
9.6.1 Europe Pain Management Drugs Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Pain Management Drugs Revenue by Country (2020-2025)
9.6.3 Europe Pain Management Drugs Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Netherlands
9.6.9 Nordic Countries
10 China
10.1 China Pain Management Drugs Revenue (2020-2031)
10.2 China Pain Management Drugs Revenue by Type (2020-2031)
10.2.1 China Pain Management Drugs Revenue by Type (2020-2025)
10.2.2 China Pain Management Drugs Revenue by Type (2026-2031)
10.3 China Pain Management Drugs Revenue Share by Type (2020-2031)
10.4 China Pain Management Drugs Revenue by Application (2020-2031)
10.4.1 China Pain Management Drugs Revenue by Application (2020-2025)
10.4.2 China Pain Management Drugs Revenue by Application (2026-2031)
10.5 China Pain Management Drugs Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Pain Management Drugs Revenue (2020-2031)
11.2 Asia Pain Management Drugs Revenue by Type (2020-2031)
11.2.1 Asia Pain Management Drugs Revenue by Type (2020-2025)
11.2.2 Asia Pain Management Drugs Revenue by Type (2026-2031)
11.3 Asia Pain Management Drugs Revenue Share by Type (2020-2031)
11.4 Asia Pain Management Drugs Revenue by Application (2020-2031)
11.4.1 Asia Pain Management Drugs Revenue by Application (2020-2025)
11.4.2 Asia Pain Management Drugs Revenue by Application (2026-2031)
11.5 Asia Pain Management Drugs Revenue Share by Application (2020-2031)
11.6 Asia Pain Management Drugs Revenue by Country
11.6.1 Asia Pain Management Drugs Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Pain Management Drugs Revenue by Country (2020-2025)
11.6.3 Asia Pain Management Drugs Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Pain Management Drugs Revenue (2020-2031)
12.2 SAMEA Pain Management Drugs Revenue by Type (2020-2031)
12.2.1 SAMEA Pain Management Drugs Revenue by Type (2020-2025)
12.2.2 SAMEA Pain Management Drugs Revenue by Type (2026-2031)
12.3 SAMEA Pain Management Drugs Revenue Share by Type (2020-2031)
12.4 SAMEA Pain Management Drugs Revenue by Application (2020-2031)
12.4.1 SAMEA Pain Management Drugs Revenue by Application (2020-2025)
12.4.2 SAMEA Pain Management Drugs Revenue by Application (2026-2031)
12.5 SAMEA Pain Management Drugs Revenue Share by Application (2020-2031)
12.6 SAMEA Pain Management Drugs Revenue by Country
12.6.1 SAMEA Pain Management Drugs Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Pain Management Drugs Revenue by Country (2020-2025)
12.6.3 SAMEA Pain Management Drugs Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.